Warfarin, Aspirin, and Their Combination in the Prevention of Stroke in Patients With Atrial Fibrillation: A Nested Case-control Study

被引：0
|
作者：
Azoulay, Laurent
Renoux, Christel
Simon, Teresa [2 ]
DellAniello, Sophie [1 ]
Suissa, Samy
机构：
[1] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
STROKE | 2010年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E215 / E216
页数：2
相关论文
共 50 条
  • [21] Warfarin vs aspirin for prevention of stroke in nonvalvular atrial fibrillation: Meta-analysis
    Benavente, O
    Hart, RG
    STROKE, 1999, 30 (01) : 241 - 241
  • [22] Association of Amiodarone Use With Acute Pancreatitis in Patients With Atrial Fibrillation: A Nested Case-Control Study
    Alonso, Alvaro
    MacLehose, Richard F.
    Lutsey, Pamela L.
    Konety, Suma
    Chen, Lin Y.
    CIRCULATION, 2014, 130
  • [23] Association of Amiodarone Use With Acute Pancreatitis in Patients With Atrial Fibrillation: A Nested Case-Control Study
    Alonso, Alvaro
    MacLehose, Richard F.
    Lutsey, Pamela L.
    Konety, Suma
    Chen, Lin Y.
    JAMA INTERNAL MEDICINE, 2015, 175 (03) : 449 - 450
  • [24] Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin - Stroke prevention in atrial fibrillation III study
    Anderson, DC
    Halperin, JL
    Hart, RG
    McAnulty, JH
    McBride, R
    Pearce, LA
    Sherman, DG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (16): : 1273 - 1277
  • [25] Non-valvular atrial fibrillation, anticoagulants and stroke: the stroke prevention and anticoagulants (SPA) case-control study
    Grimaldi-Bensouda, L.
    Le Heuzey, J. -Y.
    Ferrieres, J.
    Leys, D.
    Davy, J. -M.
    Martinez, M.
    Smadja, D.
    Ellie, E.
    Sablot, D.
    Nighoghossian, N.
    Benichou, J.
    Touze, E.
    Abenhaim, L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 769 - 770
  • [26] Non-Valvular Atrial Fibrillation, Anticoagulants and Stroke: The Stroke Prevention and Anticoagulants (SPA) Case-Control Study
    Grimaldi-Bensouda, Lamiae
    Le Heuzey, Jean-Yves
    Ferrieres, Jean
    Leys, Didier
    Davy, Jean-Marc
    Martinez, Mikel
    Smadja, Didier
    Ellie, Emmanuel
    Sablot, Denis
    Nighoghossian, Norbert
    Benichou, Jacques
    Touze, Emmanuel
    Abenhaim, Lucien
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 357 - 358
  • [27] DIFFERENTIAL EFFECT OF ASPIRIN AND WARFARIN ON STROKE SUBTYPES IN PATIENTS WITH ATRIAL-FIBRILLATION
    FEINBERG, WM
    MILLER, VT
    ROTHROCK, JF
    HART, RG
    PEARCE, LA
    STROKE, 1995, 26 (01) : 185 - 185
  • [28] ASPIRIN AND WARFARIN EFFECTIVE IN PREVENTING STROKE AND EMBOLISM IN PATIENTS WITH ATRIAL-FIBRILLATION
    HEALY, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21): : 2955 - 2955
  • [29] Prevalence and Risk Factors of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Case-Control Study
    Song, Vanling
    Chen, Jianhong
    Zhang, Vine
    Zhang, Qing
    WORLD NEUROSURGERY, 2025, 195
  • [30] Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Gorst-Rasmussen, Anders
    Skjoth, Flemming
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1172 - +
12345